Avadel pharmaceuticals plc (AVDL)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Jun'11Mar'11
Revenues:
Total revenues

12,243

10,995

14,229

17,554

16,437

20,920

19,826

29,230

33,293

-

39,675

47,105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-794

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenues

-

-

-

-

-

-

-

-

-

-

-

46,311

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product sales

-

-

-

-

-

-

-

-

-

-

-

-

51,757

-

31,340

38,165

35,353

43,647

47,313

48,602

32,726

987

4,747

2,499

3,960

-5,649

2,500

2,195

2,107

-6,934

2,063

2,053

3,378

2,290

1,624

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

750

-

747

693

863

721

0

0

0

-316

681

1,819

598

-1,089

1,192

1,650

1,273

850

1,710

2,054

2,110

2,482

3,214

Other revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,600

-

20

-

1,891

1,696

1,760

-5,173

1,625

1,926

1,872

1,981

1,926

Total revenues

-

-

-

-

-

-

-

-

-

-

-

-

52,507

-

32,087

38,858

36,216

44,368

47,313

48,602

32,726

-949

7,028

4,318

4,578

-12,085

5,583

5,541

5,140

-11,257

5,398

6,033

7,360

6,753

6,764

Operating expenses:
Cost of products

2,457

2,414

2,823

3,622

3,266

4,292

3,120

3,512

6,592

4,048

3,790

4,561

3,902

2,591

2,844

3,907

3,906

2,937

2,087

2,756

3,630

190

1,913

507

773

-3,452

1,736

1,283

995

-3,965

1,500

1,547

1,318

1,934

1,371

Research and development expenses

5,530

7,757

7,539

10,292

7,329

6,086

11,402

11,890

9,951

11,325

8,095

6,792

7,206

13,476

8,143

7,604

5,388

5,161

7,221

7,204

6,022

2,726

7,028

3,600

3,944

-6,547

6,680

7,304

8,529

-5,395

6,246

7,722

5,985

5,946

7,758

Selling, general and administrative expenses

7,913

7,663

5,316

6,758

10,446

23,200

24,829

27,843

24,487

23,056

11,563

12,429

11,812

10,688

12,740

11,290

9,461

6,808

4,568

5,873

4,463

4,012

4,105

4,065

3,516

5,094

2,925

2,706

2,491

2,950

3,107

2,913

5,183

2,528

2,526

Fair value remeasurement of acquisition liabilities, with related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,865

12,607

14,626

-

1,043

28,623

2,976

-

-1,060

-182

-

-

-

Remeasurement of acquisition liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,080

0

0

Intangible asset amortization

203

206

205

204

201

1,623

1,620

1,609

1,767

1,967

564

564

564

2,970

3,702

3,702

3,514

3,141

3,141

3,139

3,143

2,937

2,937

2,938

2,937

0

0

0

0

-

-

-

-

-

-

Business Combination, Acquisition Related Costs

2,478

-1,539

627

-377

2,134

-5,695

-7,115

-12,889

2,968

-933

-9,906

-13,230

-6,971

-3,704

20,848

23,898

8,243

-51,079

44,782

32,000

5,254

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring costs

159

-

1,866

1,506

1,228

-

65

50

153

-

-549

1,069

2,653

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on early repayment of related party acquisition-related note

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,013

0

0

0

0

-

-

-

-

-

-

Total operating expenses

18,740

18,342

18,376

22,005

24,604

96,341

33,921

32,015

45,918

38,832

13,557

12,185

19,166

26,021

48,277

50,401

30,512

-33,032

61,799

50,972

22,512

32,258

23,848

23,717

28,809

-9,412

12,384

39,916

14,991

-14,236

11,913

12,364

7,406

10,408

11,655

Operating loss

-6,497

-7,347

-4,147

-4,451

-8,167

-75,421

-14,095

-2,785

-12,625

-4,080

26,118

34,126

33,341

17,064

-16,190

-11,543

5,704

77,400

-14,486

-2,370

10,214

-33,207

-16,820

-19,399

-24,231

-2,673

-6,801

-34,375

-9,851

2,979

-6,515

-6,331

-46

-3,655

-4,891

Investment and other income, net

-378

-1,479

781

950

817

-393

208

583

54

-426

977

764

821

1,678

490

390

200

65

197

310

664

-

86

-

45

2,011

-688

-640

-429

-

122

-

-

-

-

Net interest income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

123

-

-

-

-

-

-

-

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

5,552

-

-

-

-

-

-

-

-

-

-

Interest income net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

250

166

197

128

Interest expense

3,190

3,190

3,125

3,106

3,062

3,045

3,000

2,980

1,597

263

263

263

263

261

264

263

175

0

0

0

0

3,026

1,486

1,079

156

574

13

2,015

0

-

0

0

-

-

-

Loss on deconsolidation of subsidiary

0

162

0

-167

-2,673

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense - changes in fair value of contingent consideration payable

-310

118

-139

-50

-307

467

425

1,402

-395

-917

768

1,670

550

-413

-1,828

-2,773

-1,534

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense - changes in fair value of related party payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,644

2,726

259

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign exchange (loss) gain

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,249

1,680

-2,941

2,498

160

-3,565

11,501

3,326

8,074

292

179

-118

-161

-33

24

-108

-95

156

-133

20

-240

Other Income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71

-

52

-

66

501

-35

11

15

9

67

42

99

Loss before income taxes

-10,375

-11,736

-6,630

-6,824

-13,392

-78,392

-16,462

-3,780

-14,563

-5,686

27,600

36,297

34,449

18,080

-16,543

-12,509

1,254

84,709

-20,773

-8,351

22,120

-30,330

-10,075

-20,063

-29,663

-3,303

-7,597

-36,562

-10,291

2,866

-6,473

-5,916

54

-3,396

-4,904

Income tax benefit

-9,510

-8,997

2,234

1,781

-374

-14,533

-691

-342

-2,327

2,559

5,921

7,370

8,539

13,346

3,451

7,449

7,312

9,625

7,302

8,507

10,473

2,050

-29

137

-2,802

-4,846

-1,228

-3,708

-1,462

-4,724

-48

1

42

63

23

Net income (loss) from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-20,200

-26,861

-

-

-

-

-

-

-

-

-

-

Net income from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-873

223

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Attributable to Parent

-865

-2,739

-8,864

-8,605

-13,018

-63,859

-15,771

-3,438

-12,236

-8,245

21,679

28,927

25,910

4,734

-19,994

-19,958

-6,058

75,084

-28,075

-16,858

11,647

-27,712

-10,046

-21,073

-26,638

5,127

-6,369

-32,854

-8,829

9,102

-6,425

-5,917

12

-3,459

-4,927

Earnings Per Share [Abstract]
Continuing operations (in usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.95

-

-

-

-

-

-

-

-

-

-

Discontinued operations (in usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.01

-

-

-

-

-

-

-

-

-

-

Net income (loss) per share - basic (in dollars per share)

-0.02

-0.07

-0.24

-0.23

-0.35

-1.71

-0.43

-0.09

-0.32

-0.18

0.54

0.70

0.63

0.11

-0.48

-0.48

-0.15

1.85

-0.69

-0.42

0.29

-

-0.26

-

-0.94

0.20

-0.25

-1.29

-0.35

0.37

-0.26

-0.24

0.00

-0.14

-0.20

Continuing operations (in usd per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.95

-

-

-

-

-

-

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.01

-

-

-

-

-

-

-

-

-

-

Net income (loss) per share - diluted (in dollars per share)

-0.02

-0.07

-0.24

-0.23

-0.35

-1.71

-0.43

-0.09

-0.32

-0.18

0.52

0.68

0.61

0.11

-0.48

-0.48

-0.15

1.80

-0.69

-0.42

0.27

-

-0.26

-

-0.94

0.20

-0.25

-1.29

-0.35

0.37

-0.26

-0.24

0.00

-0.14

-0.20

Weighted average number of shares outstanding
Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.53

-

-

-

-

-

-

-

-

-

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.02

-

-

-

-

-

-

-

-

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.55

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of shares outstanding - basic (in shares)

41,057

37,466

37,436

37,356

37,354

37,065

36,904

36,772

38,559

39,334

40,061

41,091

41,374

41,269

41,241

41,241

41,241

41,135

40,625

40,353

40,207

39,339

38,767

38,438

28,312

50,894

25,465

25

25,415

25,214

25,157

25,157

25,012

24

24,646

Weighted average number of shares outstanding - diluted (in shares)

41,057

37,466

37,436

37,356

37,354

37,065

36,904

36,772

38,559

40,424

41,339

42,487

42,810

41,269

41,241

41,241

41,241

50,619

40,625

40,353

42,879

39,339

38,767

38,438

28,312

50,894

25,465

25

25,415

25,214

25,157

25,157

25,012

24

24,646

Product sales
Total revenues

-

-

14,229

17,554

-

19,320

19,826

29,116

33,161

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue
Total revenues

-

-

0

0

-

1,600

0

114

132

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-